AC-101 Tablets

AC-101 · Accro Bioscience (Suzhou) Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AC-101 Tablets, covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis [Phase 1, Phase 2]